Giant cell arteritis presenting as a supraclavicular nodule

All of RECERCAT

To access the full text documents, please follow this link: http://hdl.handle.net/2445/22427

dc.contributor	Universitat de Barcelona
dc.contributor.author	Vivancos, Josep
dc.contributor.author	Bosch Aparici, Francisco Javier
dc.contributor.author	López-Soto, Alfonso
dc.contributor.author	Font Franco, Josep, 1953-2006
dc.contributor.author	Ribera, J. M.
dc.contributor.author	Ingelmo Morín, Miguel
dc.date	2012-03-05T12:51:59Z
dc.date	2012-03-05T12:51:59Z
dc.date	1990
dc.identifier.citation	0003-4967
dc.identifier.citation	64148
dc.identifier.uri	http://hdl.handle.net/2445/22427
dc.format	2 p.
dc.format	application/pdf
dc.language.iso	eng
dc.publisher	BMJ Group
dc.relation	Reproducció digital del document publicat a: http://dx.doi.org/10.1136/ard.49.3.202-c
dc.relation	Annals of the Rheumatic Diseases, 1990, vol. 49, núm. 3, p. 202-203
dc.relation	http://dx.doi.org/10.1136/ard.49.3.202-c
dc.rights	(c) BMJ Publishing Group Ltd, 1990
dc.rights	info:eu-repo/semantics/openAccess
dc.subject	Arteritis de cèl·lules gegants
dc.subject	Giant cell arteritis
dc.title	Giant cell arteritis presenting as a supraclavicular nodule
dc.type	info:eu-repo/semantics/article
dc.type	info:eu-repo/semantics/publishedVersion
dc.description.abstract	Letters to the editor: Sir: We read with great interest the article by Englert and colleagues on their experiences with sulphasalazine treatment in rheumatoid arthritis (RA).' They noted the disappearance of rheumatoid nodules in four patients with RA in eight to 12 weeks after the start of treatment, parallel with a decrease in disease activity.